Preserving female fertility following cancer treatment: Current options and future possibilities

Erin R. West, Mary Zelinski, Laxmi A. Kondapalli, Clarisa Gracia, Jeffrey Chang, Christos Coutifaris, John Critser, Richard Stouffer, Lonnie D. Shea, Teresa K. Woodruff

    Research output: Contribution to journalArticle

    51 Citations (Scopus)

    Abstract

    Children and women of reproductive age are increasingly surviving cancer diagnoses, and therefore long-term quality-of-life issues are of greater importance at the time of diagnosis. Cancer therapies including radiation and chemotherapy can be detrimental to fertility, and therefore many patients are motivated to preserve fertility prior to cancer treatment. The only highly successful method in preserving fertility to date is embryo cryopreservation, which may not be appropriate for some patients due to age, delay in treatment, cancer type and stage, as well as availability of an acceptable sperm donor. Alternative methods including oocyte cryopreservation and ovarian tissue banking may also preserve fertility while providing additional flexibility to patients. In vitro ovarian follicle maturation following tissue banking is one potential approach that would not require a delay in cancer therapy for ovarian stimulation, would not require an immediate sperm donor, and does not carry the risk of reintroducing malignant cells following tissue transplantation. In vitro follicle culture systems have resulted in successful live births in the mouse. However, many challenges must be addressed in translating the system to the human. This review summarizes current approaches to fertility preservation and discusses recent developments and future challenges in developing a human in vitro follicle culture system.

    Original languageEnglish (US)
    Pages (from-to)289-295
    Number of pages7
    JournalPediatric Blood and Cancer
    Volume53
    Issue number2
    DOIs
    StatePublished - Aug 2009

    Fingerprint

    Fertility
    Tissue Banks
    Cryopreservation
    Neoplasms
    Spermatozoa
    Tissue Donors
    Fertility Preservation
    Therapeutics
    Tissue Transplantation
    Ovarian Follicle
    Ovulation Induction
    Live Birth
    Oocytes
    Radiotherapy
    Embryonic Structures
    Quality of Life
    Drug Therapy
    In Vitro Techniques

    Keywords

    • Fertility preservation
    • Follicle
    • Oncofertility

    ASJC Scopus subject areas

    • Oncology
    • Pediatrics, Perinatology, and Child Health
    • Hematology
    • Medicine(all)

    Cite this

    West, E. R., Zelinski, M., Kondapalli, L. A., Gracia, C., Chang, J., Coutifaris, C., ... Woodruff, T. K. (2009). Preserving female fertility following cancer treatment: Current options and future possibilities. Pediatric Blood and Cancer, 53(2), 289-295. https://doi.org/10.1002/pbc.21999

    Preserving female fertility following cancer treatment : Current options and future possibilities. / West, Erin R.; Zelinski, Mary; Kondapalli, Laxmi A.; Gracia, Clarisa; Chang, Jeffrey; Coutifaris, Christos; Critser, John; Stouffer, Richard; Shea, Lonnie D.; Woodruff, Teresa K.

    In: Pediatric Blood and Cancer, Vol. 53, No. 2, 08.2009, p. 289-295.

    Research output: Contribution to journalArticle

    West, ER, Zelinski, M, Kondapalli, LA, Gracia, C, Chang, J, Coutifaris, C, Critser, J, Stouffer, R, Shea, LD & Woodruff, TK 2009, 'Preserving female fertility following cancer treatment: Current options and future possibilities', Pediatric Blood and Cancer, vol. 53, no. 2, pp. 289-295. https://doi.org/10.1002/pbc.21999
    West, Erin R. ; Zelinski, Mary ; Kondapalli, Laxmi A. ; Gracia, Clarisa ; Chang, Jeffrey ; Coutifaris, Christos ; Critser, John ; Stouffer, Richard ; Shea, Lonnie D. ; Woodruff, Teresa K. / Preserving female fertility following cancer treatment : Current options and future possibilities. In: Pediatric Blood and Cancer. 2009 ; Vol. 53, No. 2. pp. 289-295.
    @article{c5f2cd18429a4470802fbcf021116167,
    title = "Preserving female fertility following cancer treatment: Current options and future possibilities",
    abstract = "Children and women of reproductive age are increasingly surviving cancer diagnoses, and therefore long-term quality-of-life issues are of greater importance at the time of diagnosis. Cancer therapies including radiation and chemotherapy can be detrimental to fertility, and therefore many patients are motivated to preserve fertility prior to cancer treatment. The only highly successful method in preserving fertility to date is embryo cryopreservation, which may not be appropriate for some patients due to age, delay in treatment, cancer type and stage, as well as availability of an acceptable sperm donor. Alternative methods including oocyte cryopreservation and ovarian tissue banking may also preserve fertility while providing additional flexibility to patients. In vitro ovarian follicle maturation following tissue banking is one potential approach that would not require a delay in cancer therapy for ovarian stimulation, would not require an immediate sperm donor, and does not carry the risk of reintroducing malignant cells following tissue transplantation. In vitro follicle culture systems have resulted in successful live births in the mouse. However, many challenges must be addressed in translating the system to the human. This review summarizes current approaches to fertility preservation and discusses recent developments and future challenges in developing a human in vitro follicle culture system.",
    keywords = "Fertility preservation, Follicle, Oncofertility",
    author = "West, {Erin R.} and Mary Zelinski and Kondapalli, {Laxmi A.} and Clarisa Gracia and Jeffrey Chang and Christos Coutifaris and John Critser and Richard Stouffer and Shea, {Lonnie D.} and Woodruff, {Teresa K.}",
    year = "2009",
    month = "8",
    doi = "10.1002/pbc.21999",
    language = "English (US)",
    volume = "53",
    pages = "289--295",
    journal = "Pediatric Blood and Cancer",
    issn = "1545-5009",
    publisher = "Wiley-Liss Inc.",
    number = "2",

    }

    TY - JOUR

    T1 - Preserving female fertility following cancer treatment

    T2 - Current options and future possibilities

    AU - West, Erin R.

    AU - Zelinski, Mary

    AU - Kondapalli, Laxmi A.

    AU - Gracia, Clarisa

    AU - Chang, Jeffrey

    AU - Coutifaris, Christos

    AU - Critser, John

    AU - Stouffer, Richard

    AU - Shea, Lonnie D.

    AU - Woodruff, Teresa K.

    PY - 2009/8

    Y1 - 2009/8

    N2 - Children and women of reproductive age are increasingly surviving cancer diagnoses, and therefore long-term quality-of-life issues are of greater importance at the time of diagnosis. Cancer therapies including radiation and chemotherapy can be detrimental to fertility, and therefore many patients are motivated to preserve fertility prior to cancer treatment. The only highly successful method in preserving fertility to date is embryo cryopreservation, which may not be appropriate for some patients due to age, delay in treatment, cancer type and stage, as well as availability of an acceptable sperm donor. Alternative methods including oocyte cryopreservation and ovarian tissue banking may also preserve fertility while providing additional flexibility to patients. In vitro ovarian follicle maturation following tissue banking is one potential approach that would not require a delay in cancer therapy for ovarian stimulation, would not require an immediate sperm donor, and does not carry the risk of reintroducing malignant cells following tissue transplantation. In vitro follicle culture systems have resulted in successful live births in the mouse. However, many challenges must be addressed in translating the system to the human. This review summarizes current approaches to fertility preservation and discusses recent developments and future challenges in developing a human in vitro follicle culture system.

    AB - Children and women of reproductive age are increasingly surviving cancer diagnoses, and therefore long-term quality-of-life issues are of greater importance at the time of diagnosis. Cancer therapies including radiation and chemotherapy can be detrimental to fertility, and therefore many patients are motivated to preserve fertility prior to cancer treatment. The only highly successful method in preserving fertility to date is embryo cryopreservation, which may not be appropriate for some patients due to age, delay in treatment, cancer type and stage, as well as availability of an acceptable sperm donor. Alternative methods including oocyte cryopreservation and ovarian tissue banking may also preserve fertility while providing additional flexibility to patients. In vitro ovarian follicle maturation following tissue banking is one potential approach that would not require a delay in cancer therapy for ovarian stimulation, would not require an immediate sperm donor, and does not carry the risk of reintroducing malignant cells following tissue transplantation. In vitro follicle culture systems have resulted in successful live births in the mouse. However, many challenges must be addressed in translating the system to the human. This review summarizes current approaches to fertility preservation and discusses recent developments and future challenges in developing a human in vitro follicle culture system.

    KW - Fertility preservation

    KW - Follicle

    KW - Oncofertility

    UR - http://www.scopus.com/inward/record.url?scp=67649999227&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=67649999227&partnerID=8YFLogxK

    U2 - 10.1002/pbc.21999

    DO - 10.1002/pbc.21999

    M3 - Article

    C2 - 19301373

    AN - SCOPUS:67649999227

    VL - 53

    SP - 289

    EP - 295

    JO - Pediatric Blood and Cancer

    JF - Pediatric Blood and Cancer

    SN - 1545-5009

    IS - 2

    ER -